JPY 4380.0
(2.46%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 133.43 Billion JPY | -0.19% |
2022 | 133.68 Billion JPY | 2.2% |
2021 | 130.81 Billion JPY | 3.8% |
2020 | 126.02 Billion JPY | -9.94% |
2019 | 139.94 Billion JPY | 35.15% |
2018 | 103.54 Billion JPY | -1.14% |
2017 | 104.74 Billion JPY | 6.31% |
2016 | 98.52 Billion JPY | -0.35% |
2015 | 98.86 Billion JPY | 6.83% |
2014 | 92.55 Billion JPY | -0.63% |
2013 | 93.13 Billion JPY | 1.96% |
2012 | 91.35 Billion JPY | 4.12% |
2011 | 87.73 Billion JPY | 3.36% |
2010 | 84.88 Billion JPY | -0.88% |
2009 | 85.63 Billion JPY | 5.16% |
2008 | 81.43 Billion JPY | 1.24% |
2007 | 80.43 Billion JPY | 3.74% |
2006 | 77.54 Billion JPY | 0.99% |
2005 | 76.78 Billion JPY | 3.7% |
2004 | 74.04 Billion JPY | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 132.94 Billion JPY | -0.36% |
2024 Q2 | 134.34 Billion JPY | 1.05% |
2024 Q3 | 134.61 Billion JPY | 0.2% |
2023 Q4 | 133.43 Billion JPY | 0.95% |
2023 Q1 | 129.57 Billion JPY | -3.08% |
2023 Q3 | 132.18 Billion JPY | 0.39% |
2023 FY | 133.43 Billion JPY | -0.19% |
2023 Q2 | 131.67 Billion JPY | 1.62% |
2022 Q2 | 130.8 Billion JPY | 1.14% |
2022 Q4 | 133.68 Billion JPY | 3.09% |
2022 FY | 133.68 Billion JPY | 2.2% |
2022 Q1 | 129.33 Billion JPY | -1.13% |
2022 Q3 | 129.67 Billion JPY | -0.86% |
2021 Q4 | 130.81 Billion JPY | 1.6% |
2021 FY | 130.81 Billion JPY | 3.8% |
2021 Q1 | 127.28 Billion JPY | 1.0% |
2021 Q2 | 126.52 Billion JPY | -0.6% |
2021 Q3 | 128.75 Billion JPY | 1.76% |
2020 Q2 | 124.73 Billion JPY | 0.62% |
2020 Q1 | 123.96 Billion JPY | -11.42% |
2020 FY | 126.02 Billion JPY | -9.94% |
2020 Q4 | 126.02 Billion JPY | 1.28% |
2020 Q3 | 124.43 Billion JPY | -0.24% |
2019 Q4 | 139.94 Billion JPY | -4.95% |
2019 FY | 139.94 Billion JPY | 35.15% |
2019 Q2 | 148.58 Billion JPY | -0.14% |
2019 Q1 | 148.78 Billion JPY | 43.69% |
2019 Q3 | 147.23 Billion JPY | -0.91% |
2018 Q4 | 103.54 Billion JPY | -1.15% |
2018 FY | 103.54 Billion JPY | -1.14% |
2018 Q1 | 102.48 Billion JPY | -2.15% |
2018 Q2 | 103.6 Billion JPY | 1.09% |
2018 Q3 | 104.75 Billion JPY | 1.11% |
2017 Q4 | 104.74 Billion JPY | 4.36% |
2017 Q2 | 98.78 Billion JPY | 0.96% |
2017 Q1 | 97.84 Billion JPY | -0.69% |
2017 Q3 | 100.36 Billion JPY | 1.6% |
2017 FY | 104.74 Billion JPY | 6.31% |
2016 Q3 | 96.71 Billion JPY | -0.99% |
2016 FY | 98.52 Billion JPY | -0.35% |
2016 Q2 | 97.67 Billion JPY | -0.19% |
2016 Q4 | 98.52 Billion JPY | 1.88% |
2016 Q1 | 97.86 Billion JPY | -1.02% |
2015 Q2 | 94.46 Billion JPY | 0.37% |
2015 Q3 | 98.2 Billion JPY | 3.95% |
2015 Q1 | 94.11 Billion JPY | 0.0% |
2015 FY | 98.86 Billion JPY | 6.83% |
2015 Q4 | 98.86 Billion JPY | 0.68% |
2014 Q1 | 93.13 Billion JPY | 2.73% |
2014 FY | 92.55 Billion JPY | -0.63% |
2014 Q3 | 92.73 Billion JPY | 2.11% |
2014 Q2 | 90.82 Billion JPY | -2.48% |
2013 Q4 | 90.65 Billion JPY | 0.9% |
2013 Q1 | 91.35 Billion JPY | 0.42% |
2013 Q2 | 88.09 Billion JPY | -3.56% |
2013 Q3 | 89.85 Billion JPY | 2.0% |
2013 FY | 93.13 Billion JPY | 1.96% |
2012 Q3 | 89.87 Billion JPY | 4.9% |
2012 FY | 91.35 Billion JPY | 4.12% |
2012 Q4 | 90.96 Billion JPY | 1.22% |
2012 Q2 | 85.67 Billion JPY | -2.35% |
2012 Q1 | 87.73 Billion JPY | 1.9% |
2011 Q3 | 85.38 Billion JPY | 0.77% |
2011 FY | 87.73 Billion JPY | 3.36% |
2011 Q1 | 84.88 Billion JPY | -1.29% |
2011 Q2 | 84.73 Billion JPY | -0.18% |
2011 Q4 | 86.1 Billion JPY | 0.84% |
2010 Q1 | 85.63 Billion JPY | 1.59% |
2010 Q3 | 85.81 Billion JPY | 2.27% |
2010 Q4 | 85.99 Billion JPY | 0.21% |
2010 FY | 84.88 Billion JPY | -0.88% |
2010 Q2 | 83.91 Billion JPY | -2.01% |
2009 Q4 | 84.29 Billion JPY | 1.48% |
2009 FY | 85.63 Billion JPY | 5.16% |
2009 Q3 | 83.06 Billion JPY | 0.0% |
2009 Q1 | 81.43 Billion JPY | 2.38% |
2008 FY | 81.43 Billion JPY | 1.24% |
2008 Q4 | 79.54 Billion JPY | 0.0% |
2007 FY | 80.43 Billion JPY | 3.74% |
2006 FY | 77.54 Billion JPY | 0.99% |
2005 FY | 76.78 Billion JPY | 3.7% |
2004 FY | 74.04 Billion JPY | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 36.57 Billion JPY | -264.837% |
Takeda Pharmaceutical Company Limited | 15108.79 Billion JPY | 99.117% |
Sumitomo Pharma Co., Ltd. | 907.5 Billion JPY | 85.297% |
Shionogi & Co., Ltd. | 1416.91 Billion JPY | 90.583% |
Wakamoto Pharmaceutical Co.,Ltd. | 15.42 Billion JPY | -765.259% |
Nippon Shinyaku Co., Ltd. | 263.4 Billion JPY | 49.343% |
Kaken Pharmaceutical Co., Ltd. | 171.62 Billion JPY | 22.253% |
Eisai Co., Ltd. | 1393.79 Billion JPY | 90.427% |
Morishita Jintan Co., Ltd. | 17.18 Billion JPY | -676.535% |
Hisamitsu Pharmaceutical Co., Inc. | 328.77 Billion JPY | 59.416% |
Mochida Pharmaceutical Co., Ltd. | 158.8 Billion JPY | 15.975% |
Fuso Pharmaceutical Industries,Ltd. | 76.46 Billion JPY | -74.512% |
Nippon Chemiphar Co., Ltd. | 49.54 Billion JPY | -169.298% |
Tsumura & Co. | 428.25 Billion JPY | 68.843% |
Kissei Pharmaceutical Co., Ltd. | 260.92 Billion JPY | 48.863% |
Towa Pharmaceutical Co., Ltd. | 430.65 Billion JPY | 69.016% |
Fuji Pharma Co., Ltd. | 85.33 Billion JPY | -56.368% |
Zeria Pharmaceutical Co., Ltd. | 150.53 Billion JPY | 11.361% |
KYORIN Holdings, Inc. | 177.67 Billion JPY | 24.903% |
Taiko Pharmaceutical Co.,Ltd. | 15.04 Billion JPY | -786.827% |
Daito Pharmaceutical Co.,Ltd. | 77.7 Billion JPY | -71.709% |
SymBio Pharmaceuticals Limited | 15.35 Billion JPY | -769.148% |
MedRx Co., Ltd | 2.05 Billion JPY | -6402.534% |
Mizuho Medy Co.,Ltd. | 18.94 Billion JPY | -604.189% |
Solasia Pharma K.K. | 2.55 Billion JPY | -5132.627% |
Modalis Therapeutics Corporation | 2.02 Billion JPY | -6486.226% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 93.31 Billion JPY | -42.996% |
Sawai Group Holdings Co., Ltd. | 382.02 Billion JPY | 65.072% |
Cyfuse Biomedical K.K. | 4.21 Billion JPY | -3065.79% |
Toho Holdings Co., Ltd. | 773.42 Billion JPY | 82.748% |
Koa Shoji Holdings Co.,Ltd. | 32 Billion JPY | -316.923% |